Medwave seeks buyer
This article was originally published in The Gray Sheet
Executive Summary
Maker of non-invasive blood pressure measurement and monitoring systems is exploring "strategic alternatives," including the possible sale of the company, Medwave says April 10. The firm disclosed in its recent annual report that continued net losses and an accumulated deficit of about $34 million "raise substantial doubt about the company's ability to continue as a going concern." In January, Medwave received a delisting warning from the Nasdaq stock market when its share price traded below $1 for more than 30 days in a row...